Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_13-cv-04001/USCOURTS-cand-5_13-cv-04001-13/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

Case No.: 13-CV-04001-LHK

ORDER CONTINUING CASE MANAGEMENT CONFERENCE

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

TAKEDA PHARMACEUTICAL CO., 

LTD., et al.,

Plaintiffs,

v.

MYLAN INC., et al.,

Defendants.

Case No.: 13-CV-04001-LHK

ORDER CONTINUING CASE 

MANAGEMENT CONFERENCE

In light of the Court’s order staying all deadlines for 45 days pending regulatory review of 

the parties’ settlement, ECF No. 158, the case management conference set for March 19, 2015, is 

hereby CONTINUED to April 22, 2015, at 2:00 p.m., should it be necessary following the 

regulatory review period.

IT IS SO ORDERED.

Dated: February 27, 2015

______________________________________

LUCY H. KOH

United States District Judge

Case 5:13-cv-04001-LHK Document 159 Filed 02/27/15 Page 1 of 1